The Italian Society of Pharmacology (SIF) announced, during its 42nd National Congress, the appointments of Armando Gena...
Next-generation psychedelics: should new agents skip the trip?
Background Depression affects around 280 million worldwide and one of the major unmet needs is the limited efficacy of t...
New Horizons in Type 1 Diabetes: FDA Approval of Lantidra and Emerging Therapies
The FDA has approved Lantidra, a groundbreaking donor-derived pancreatic islet cell therapy for type 1 diabetes, providi...
Why gene therapies must go virus-free
Gene therapies have made spectacular progress in delivering new cures for previously intractable disease, where virus ve...
Advancement in Metabolic dysfunction-Associated SteatoHepatitis (MASH) treatment: the first FDA approved drug
The FDA approves Madrigal Pharmaceuticals’ Rezdiffra for Metabolic dysfunction-Associated SteatoHepatitis (MASH), ...
First amniotic fluid-derived human organoids will advance prenatal precision medicine in a new era.
Researchers created 3D models of developing organs from fetal cells, which are present in amniotic fluid, to help prenat...